CIK 0001652130 · Large accelerated filer
Intellia Therapeutics, Inc.
Sign in to watch- Ticker
- NTLA
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364785571
- Phone
- 857-285-6200
- Business address
- 400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $417,899
- in 3 filings, $395K under 10b5-1 plans
Net −$417,899. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 7 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-03 | SCHIERMEIER ANDREW EVP, Chief Operating Officer | Grant or award · Stock Option (right to buy) | +78,750 | 78,750 | ||
| 2021-03-03 | SCHIERMEIER ANDREW EVP, Chief Operating Officer | Grant or award · Restricted Stock Unit | +13,125 | 13,125 | ||
| 2021-03-03 | Rivera Jose E EVP, General Counsel | Grant or award · Stock Option (right to buy) | +73,500 | 73,500 | ||
| 2021-03-03 | Rivera Jose E EVP, General Counsel | Grant or award · Restricted Stock Unit | +12,250 | 12,250 | ||
| 2021-03-03 | LEONARD JOHN M President and CEO | Grant or award · Stock Option (right to buy) | +188,363 | 188,363 | ||
| 2021-03-03 | LEONARD JOHN M President and CEO | Grant or award · Restricted Stock Unit | +31,394 | 31,394 | ||
| 2021-03-03 | Lebwohl David EVP, Chief Medical Officer | Grant or award · Stock Option (right to buy) | +76,500 | 76,500 | ||
| 2021-03-03 | Lebwohl David EVP, Chief Medical Officer | Grant or award · Restricted Stock Unit | +12,750 | 12,750 | ||
| 2021-03-03 | Goddard Glenn EVP, Chief Financial Officer | Grant or award · Stock Option (right to buy) | +73,500 | 73,500 | ||
| 2021-03-03 | Goddard Glenn EVP, Chief Financial Officer | Grant or award · Restricted Stock Unit | +12,250 | 12,250 | ||
| 2021-02-26 | FORMELA JEAN FRANCOIS Director | Sale | −501,945 | $60.29 | $30.3M | 1,113,376 |
| 2021-02-09 | Rivera Jose E EVP, General Counsel | Option exercise | +21,000 | $18.30 | $384K | 129,409 |
| 2021-02-09 | Rivera Jose E EVP, General Counsel | Sale | −11,489 | $75.00 | $862K | 117,920 |
| 2021-02-09 | Rivera Jose E EVP, General Counsel | Option exercise · Stock Option (right to buy) | −21,000 | 50,090 | ||
| 2021-02-09 | LEONARD JOHN M President and CEO | Option exercise | +56,718 | $6.83 | $387K | 688,579 |
| 2021-02-09 | LEONARD JOHN M President and CEO | Sale | −28,043 | $75.00 | $2.1M | 660,536 |
| 2021-02-09 | LEONARD JOHN M President and CEO | Option exercise · Stock Option (right to buy) | −56,718 | 68,516 | ||
| 2021-02-05 | LEONARD JOHN M President and CEO | Option exercise | +40,000 | $13.40 | $536K | 654,803 |
| 2021-02-05 | LEONARD JOHN M President and CEO | Sale | −8,043 | $67.18 | $540K | 646,760 |
| 2021-02-05 | LEONARD JOHN M President and CEO | Sale | −14,018 | $67.86 | $951K | 632,742 |
Page 25 of 40 · 783 trades